4.1 Article

Predictors of atopic dermatitis phenotypes and severity: Roles of serum immunoglobulins and filaggrin gene mutation R501X

Journal

ALLERGOLOGIA ET IMMUNOPATHOLOGIA
Volume 41, Issue 2, Pages 86-93

Publisher

ELSEVIER DOYMA SL
DOI: 10.1016/j.aller.2012.03.004

Keywords

Atopic dermatitis; Filaggrin R501X mutation; Immunoglobulin levels; Children

Ask authors/readers for more resources

Background: Atopic dermatitis (AD), the most common chronic relapsing skin condition of infancy and childhood, is a complex multifactorial disease, which arises from the interaction between strong genetic and environmental factors. Objective: To investigate the roles of several factors on the severity of AD including FLG R501X gene mutation, serum immunoglobulin (Ig) levels, atopy and accompanying allergic disorders. Method: Children were genotyped for the mutation in FLG R501X gene. Serum levels of major Ig isotypes, atopy and accompanying allergic disorders were assessed. Results: Study group consisted of 49 patients (M: 26, F: 23) with a mean age of 4.9 +/- 3.6 years and control group consisted of 50 children (M: 30, F: 20) with a mean age of 3.8 +/- 2.8 years. Genotyping of R501X mutation revealed risk alleles in none of the children in study group or control group. IgG z-scores were significantly higher in patients with AD compared to controls (-0.97 +/- 1.13 vs 1.48 +/- 1.02, p = 0.026). There was a positive trend in IgG z-scores and a negative trend in IgA z-scores across the severity of AD. History of recurrent infections was significantly associated with asthma and/or AR (47.8% in patients with asthma/AR vs 3.8% in those without). Children with low IgG or IgA levels presented at an earlier age with lower rates of atopy and mild type AD. Conclusion: In a sample of Turkish children, FLG R501X genotyping revealed no risk alleles in variable severities of AD or healthy controls. Our data suggest that IgG and IgA levels might have a role in phenotypic features of AD in terms of severity and atopic sensitisation. (c) 2011 SEICAP. Published by Elsevier Espana, S.L. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Immunology

A Patient with Novel ICOS Mutation Presented with Progressive Loss of B Cells

Asena Pinar Sefer, Louis Marie Charbonnier, Nurhan Kasap, Bengu Akcam, Yasemin Kendir Demirkol, Sevgi Bilgic Eltan, Ahmet Ozen, Elif Karakoc-Aydiner, Safa Baris

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Correction Immunology

A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma (vol 21, pg 1359, 2020)

Hani Harb, Emmanuel Stephen-Victor, Elena Crestani, Mehdi Benamar, Amir Massoud, Ye Cui, Louis-Marie Charbonnier, Sena Arbag, Safa Baris, Amparito Cunnigham, Juan Manuel Leyva-Castillo, Raif S. Geha, Amirhosein J. Mousavi, Boris Guennewig, Klaus Schmitz-Abe, Constantinos Sioutas, Wanda Phipatanakul, Talal A. Chatila

Summary: The paper has been amended and the updated version can be accessed via a link at the top of the paper.

NATURE IMMUNOLOGY (2021)

Article Immunology

A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis

Nurhan Kasap, Velat Celik, Sakine Isik, Pakize Cennetoglu, Ayca Kiykim, Sevgi Bilgic Eltan, Ercan Nain, Ismail Ogulur, Dilek Baser, Emre Akkelle, Mehmet Halil Celiksoy, Burcu Kocamis, Funda Erol Cipe, Ayse Deniz Yucelten, Elif Karakoc-Aydiner, Ahmet Ozen, Safa Baris

Summary: Hyper-IgE syndrome (HIES) patients may share similar features with severe atopic dermatitis (SAD) patients, but analyzing clinical and laboratory markers can help differentiate the two disorders. Different types of HIES have distinct characteristics, with STAT3-HIES patients exhibiting specific facial appearance and skin issues, while DOCK8 deficiency patients are prone to mucocutaneous candidiasis and Herpes infection.

CLINICAL IMMUNOLOGY (2021)

Letter Immunology

Lymphopenia with Low T and NK Cells in a Patient with USB1 Mutation, Rare Findings in Clericuzio-Type Poikiloderma with Neutropenia

Sevgi Bilgic Eltan, Asena Pinar Sefer, Ibrahim Serhat Karakus, Ahmet Ozen, Elif Karakoc-Aydiner, Safa Baris

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Homozygous IL37 mutation associated with infantile inflammatory bowel disease

Zinan Z. Zhang, Yu Zhang, Tingyan He, Colin L. Sweeney, Safa Baris, Elif Karakoc-Aydiner, Yikun Yao, Deniz Ertem, Helen F. Matthews, Claudia Gonzaga-Jauregui, Harry L. Malech, Helen C. Su, Ahmet Ozen, Kenneth G. C. Smith, Michael J. Lenardo

Summary: IL-37 mutation in a 4-month-old male from a consanguineous family led to infantile inflammatory bowel disease (I-IBD) with persistent diarrhea. The patient's cells showed increased intracellular IL-37 expression and proinflammatory cytokine production. Insights from this patient suggest a potential role of the IL-18 and IL-37 axis in colonic homeostasis.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension

Kaela Drzewiecki, Jungmin Choi, Joseph Brancale, Michael A. Leney-Greene, Sinan Sari, Buket Dalgic, Aysel Unlusoy Aksu, Gulseren Lvigen Sahin, Ahmet Ozen, Safa Baris, Elif Karakoc-Aydiner, Dhanpat Jain, David Kleiner, Michael Schmalz, Kadakkal Radhakrishnan, Junhui Zhang, Kasper Hoebe, Helen C. Su, Joao P. Pereira, Michael J. Lenardo, Richard P. Lifton, Silvia Vilarinho

Summary: Portal hypertension is a major contributor to decompensation and death from liver disease. Research shows that homozygous damaging mutations in GIMAP5 can lead to capillarization of liver endothelial cells and ultimately result in portal hypertension. Understanding the pathogenesis of advanced liver disease is crucial for developing new therapies to reduce adverse outcomes.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Hematology

Biallelic NFATC1 mutations cause an inborn error of immunity with impaired CD8+ T-cell function and perturbed glycolysis

Sevgi Kostel Bal, Sarah Giuliani, Jana Block, Peter Repiscak, Christoph Hafemeister, Tala Shahin, Nurhan Kasap, Bernhard Ransmayr, Yirun Miao, Cheryl van de Wetering, Alexandra Frohne, Raul Jimenez Heredia, Michael Schuster, Samaneh Zoghi, Vanessa Hertlein, Marini Thian, Aleksandr Bykov, Royala Babayeva, Sevgi Bilgic Eltan, Elif Karakoc-Aydiner, Lisa E. Shaw, Iftekhar Chowdhury, Markku Varjosalo, Rafael J. Arguello, Matthias Farlik, Ahmet Ozen, Edgar Serfling, Loic Dupre, Christoph Bock, Florian Halbritter, J. Thomas Hannich, Irinka Castanon, Michael J. Kraakman, Safa Baris, Kaan Boztug

Summary: In this study, the researchers investigated the role of NFATC1 mutations in human immunity and found evidence of metabolic plasticity in patient T cells. The study also demonstrated that metformin and rosiglitazone can improve the effector functions of patient T cells.

BLOOD (2023)

Meeting Abstract Immunology

A Rare Immunodeficiency As a Cause of Inflammatory Bowel Disease; ARPC1B Deficiency

Asena Pinar Sefer, Salim Can, Alper Bulutoglu, Dilek Baser, Ali Islek, Derya Ufuk Altintas, Safa Baris, Elif Karakoc Aydiner, Bernice Lo, Ahmet Ozen

CLINICAL IMMUNOLOGY (2023)

Correction Immunology

Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients (vol 255,109757, 2023)

Nalan Yakici, Alexandra Y. Kreins, Mehmet Cihangir Catak, Royala Babayeva, Baran Erman, Heather Kenney, Hatice Eke-Gungor, Pablo A. Cea, Tomoki Kawai, Marita Bosticardo, Ottavia Maria Delmonte, Stuart Adams, Yu-Tong Fan, Francesca Pala, Ayberk Turkyilmaz, Evey Howley, Austen Worth, Hakan Kot, Asena Pinar Sefer, Altan Kara, Alper Bulutoglu, Sevgi Bilgic-Eltan, Melek Yorgun Altunbas, Feyza Bayram Catak, Ibrahim Serhat Karakus, Emrah Karatay, Sidem Didar Tekeoglu, Metin Eser, Davut Albayrak, Senol Citli, Ayca Kiykim, Elif Karakoc-Aydiner, Ahmet Ozen, Sujal Ghosh, Holger Gohlke, Fazil Orhan, Luigi D. Notarangelo, E. Graham Davies, Safa Baris

CLINICAL IMMUNOLOGY (2023)

Meeting Abstract Immunology

A phase 2/3 study evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE disease)

Ahmet Ozen, Voranush Chongsrisawat, Asena Pinar Sefer, Burcu Kolukisa, Jessica J. Jalbert, Jutta L. Miller, Karoline A. Meagher, Taylor Brackin, Hagit Baris Feldman, Orly Eshach Adiv, Safa Baris, Elif Karakoc-Aydiner, Sevgi Bilgic Eltan, Melek Yorgun Altunbas, Rabia Ergelen, Ivan J. Fuss, Heather Moorman, Mary Magliocco, Helen Matthews, Beatriz E. Marciano, Narissara Suratannon, Pantipa Chatchatee, Kanya Suphapeetiporn, Caryn F. Trbovic, Michael E. Burczynski, Umesh Chaudhari, Lorah Perlee, Olivier A. Harari, Michael J. Lenardo

IMMUNOBIOLOGY (2023)

Article Gastroenterology & Hepatology

Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards

Holm H. Uhlig, Claire Booth, Judy Cho, Marla Dubinsky, Anne M. Griffiths, Bodo Grimbacher, Sophie Hambleton, Ying Huang, Kelsey Jones, Jochen Kammermeier, Hirokazu Kanegane, Sibylle Koletzko, Daniel Kotlarz, Christoph Klein, Michael J. Lenardo, Bernice Lo, Dermot P. B. Mcgovern, Ahmet Ozen, Lissy de Ridder, Frank Ruemmele, Dror S. Shouval, Scott B. Snapper, Simon P. Travis, Dan Turner, David C. Wilson, Aleixo M. Muise

Summary: This Expert Recommendation reviews the therapeutic landscape for monogenic inflammatory bowel disease (mIBD) and proposes recommendations for standardized reporting of clinical outcomes. The field of mIBD lacks randomized controlled trials and relies on retrospective observational data. More than 25 off-label therapeutics and cellular therapies have been reported, but heterogeneous reporting of outcomes hinders the generation of robust therapeutic evidence.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Respiratory System

Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines

Esra Karabiber, Ozge Atik, Fatma Merve Tepetam, Bilgehan Ergan, Arzu Ilki, Elif Karakoc Aydiner, Ahmet Ozen, Fatma Ozyer, Safa Baris

Summary: Vaccines against SARS-CoV-2 are effective in patients with inborn errors of immunity, with full immunization associated with lower hospitalization rates and shorter symptomatic duration.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX (2023)

Article Pediatrics

Vitamin B12 deficiency among asymptomatic healthy infants: its impact on the immune system

Perran Boran, Selin Yildirim, Elif Karakoc-Aydiner, Ismail Ogulur, Ahmet Ozen, Goncagul Haklar, Ahmet Koc, Tunc Akkoc, Isil Barlan

Summary: Vitamin B12 deficiency is a commonly underestimated issue in developing countries. The study found that infants with vitamin B12 deficiency had lower levels of regulatory T cells compared to the control group. While the percentage of Tregs increased after treatment, the change was not significant. Additionally, proinflammatory cytokines were reduced after vitamin supplementation, suggesting potential anti-inflammatory effects. Further research is needed to explore the clinical implications of these findings in relation to emerging allergies, autoimmune disorders, and inflammation.

MINERVA PEDIATRICS (2021)

Meeting Abstract Immunology

CARMIL2 Deficiency And Various Clinical Phenotypes: Warning Signs For Early Diagnosis

Burcu Kocamis Kolukisa, Nurhan Kasap, Sevgi Bilgic Eltan, Dilek Baser, Gamze Akgun, Asena Pinar Sefer, Yasemin Kendir Demirkol, Elif Karakoc Aydiner, Ekrem Unal, Ahmet Ozen, Safa Baris

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

No Data Available